West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Stereotaxis gains CE Mark for MAGiC catheter, boosting revenue with high margins. FDA approval expected soon. Click here to ...

Microsoft has failed to break technical resistance 3 times in the last 12 months, but recent events in its AI work have ...

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Bristol Myers Squibb announced the Phase 3 RELATIVITY-098 trial evaluating Opdualag (nivolumab and relatlimab-rmbw) for the adjuvant treatment of patients wi ...

Ianalumab, for the treatment of primary immune thrombocytopenia, was granted FDA orphan designation, according to a post on the ...

Knownwell, which so far only has one clinic in Boston and another in Dallas, sees a chance to pounce on an unaddressed need ...

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...

A third of workforce tenants at four of Palm Beach County's largest workforce apartment communities are paying market rate ...

U.S. stock futures are little changed as investors eye the January jobs report, which is expected to show slower growth and no movement in the unemployment rate, and Amazon shares are falling after ...

Notwithstanding the market volatility and geopolitical uncertainties, the primary markets continued to witness heightened listing activities and investor enthusiasm in FY25, the Survey found. “ ...

There was heightened activity in the primary markets in FY25, with India becoming the global leader in IPO listings. "India's share in global IPO listings surged to 30% in 2024, up from 17% in ...